Commercialisation & IP
Coverage of how research becomes commercial activity: university technology transfer offices and their deal terms, spinout and startup formation, equity and licensing negotiations, patent policy and national IP offices, and industry–academia partnerships. This beat tracks the institutional and legal machinery between a research result and a product, which operates on entirely different timescales and incentives from the publication system covered elsewhere.
Beats in this category
- Industry Partnerships
Research collaborations between institutions and industry: sponsored research agreements, consortium formation, corporate research funding, and the IP and publication-rights terms …
- Patents & Licensing
Patent policy and practice as it affects research: national IP office rule changes, licensing disputes and settlements, march-in and Bayh-Dole developments, and changes to the pate…
- Spinouts & Startups
Academic spinout formation and the terms that govern it — founder and institutional equity splits, seed financing structures, accelerator and venture programmes aimed at university…
- Technology Transfer Offices
How university technology transfer offices operate and change: office restructuring, deal-term benchmarks, disclosure and commercialisation policy, and the metrics TTOs are judged …
All coverage (19)
- CMU’s $240M Deep Tech Venture-Ready Program
Carnegie Mellon’s Swartz Center for Entrepreneurship launched a Deep Tech Venture-Ready Program in April 2026 backed by $240M in soft-circled capital from 30 VC and corporate partners — a distinct mod…
- PMAC Opens: What It Means for University TTOs
The UPC’s Patent Mediation and Arbitration Centre opened in phases from May 12, 2026 — what it means for university patent-licensing and enforcement strategy.…
- UK Spinout Equity Stakes Hit Decade Low, RAEng Reports
The Royal Academy of Engineering’s 2026 Spotlight on Spinouts report finds UK universities’ average spinout equity stake has fallen to 16%, a decade low, down from 22% the year before — with life scie…
- Duke Migrates Research Data Repository to TIND RDM
Duke University Libraries has completed migrating its Research Data Repository from the Hyrax/Samvera stack to TIND RDM, a platform built by CERN spinoff TIND, adding a submission dashboard, dataset v…
- Argentina INPI Resolution 38/2026 Explained
Argentina’s INPI Resolution 38/2026 simplifies technology transfer agreement registration under Law 22,426, easing tax-relevant filings for global licensors.…
- Nigeria’s NIPPS and University Tech Transfer
Nigeria’s Federal Executive Council approved the National Intellectual Property Policy and Strategy (NIPPS) on November 6, 2025, and the government launched implementation on December 17, 2025. Here i…
- EO 14411: Quantum Research Security Rules
EO 14411 (June 22, 2026) tightens research-security and export-control coordination for quantum research. What it means for QIST funding and tech transfer.…
- Cambia Sells The Lens: What Changes for Users
In June 2026, Cambia sold The Lens to a new Australian non-profit under SPIE. Here’s what changes, and what does not, for Lens.org researchers.…
- MALMAD Renews Israel’s OA Deals Through 2028
MALMAD, Israel’s national open-access consortium renewed its deal with The Company of Biologists through 2028, part of a staggered publisher portfolio.…
- The PREVAIL Act’s Stalled 2026 Progress: What the Proposed PTAB Reform Would Mean for Universities
The PREVAIL Act would tighten PTAB patent-challenge rules, but 2026 progress has stalled in committee — what it means for university TTOs.…
- CRKN’s 2026 Licensing Negotiations: How Canada’s National Research Library Consortium Works
CRKN, Canada’s national library consortium, is negotiating 2026 licenses with Elsevier, Sage, Springer Nature, T&F, and Wiley on cost and transparency.…
- Bibsam Consortium Ends Hybrid Read & Publish Deals: Sweden’s 2026 Pivot to Gold-Only Agreements
Sweden’s Bibsam Consortium, coordinated by the National Library of Sweden, has adopted an action plan to stop signing hybrid read-and-publish agreements from 2026 onward, negotiating only with fully o…
- Gr-ADI: Inside the Gates-Novo Nordisk-Wellcome Antibiotic Discovery Consortium
Gates Foundation, Novo Nordisk Foundation, and Wellcome launched Gr-ADI in January 2026 with $60 million for 18 antibiotic-discovery projects in 17 countries — the first major investment inside their …
- Senate Judiciary’s July 2026 PERA Hearing: Stakes for University Diagnostics and AI Patents
Senate Judiciary July 14, 2026 hearing on PERA (S.1546) weighed patent eligibility for diagnostics and AI — key stakes for university tech transfer.…
- China’s 2026 MIIT Technology Contract Registration Rules: New Tax-Incentive Requirements for Tech Transfer Deals
MIIT’s revised technology contract registration rules, effective March 1 2026, tie VAT/CIT tax breaks to registered transfer, licensing, and R&D contracts.…
- PTAB Reaffirms Broad Institute’s CRISPR-Cas9 Eukaryotic-Cell Patent Priority (March 2026)
PTAB again ruled Broad/MIT/Harvard, not UC Berkeley’s CVC, invented eukaryotic CRISPR-Cas9 first — reaffirming priority on Federal Circuit remand.…
- Commerce Department’s Bayh-Dole March-In Proceeding Against Harvard: The 2025 Test Case
Commerce opened a Bayh-Dole march-in proceeding against Harvard’s patents in Aug. 2025 — the first agency-initiated test of march-in rights.…
- NIH’s New Access Planning Requirement for Patent Licenses: What Commercial Licensees Must Now Submit
Since October 1, 2025, applicants for commercial patent licenses on NIH-owned (intramural) inventions must submit an access plan addressing affordability, availability, acceptability, and sustainabili…
- Scholarly Publisher AI Licensing Deals: Inside the 2026 Numbers
Wiley disclosed $49M in FY2026 AI licensing revenue ($110M lifetime). Taylor & Francis and Springer Nature show similar deals; small publishers see little.…
